CEimpact Podcast

CEimpact
  • 4.8 (17)
  • COURSES
  • UPDATED WEEKLY

The CEimpact Podcast features two shows:  GameChangers Clinical Updates  Precept2Practice GameChangers Clinical Update Series: The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/  Precept2PracticeThe Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence.  New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!  Check back each week for our latest episodes. 

  1. Microdose Lithium in Alzheimer's Treatment

    2D AGO

    Microdose Lithium in Alzheimer's Treatment

    Recent preclinical studies highlight the potential of micro‑dosed lithium to modulate Alzheimer’s disease pathology and support neuronal health. This episode examines the molecular mechanisms, current evidence in Alzheimer’s models, and emerging considerations for safe use and monitoring. You will gain insights to navigate this evolving topic and support informed discussions around lithium micro‑dosing in Alzheimer’s care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Dawn Gerber, PharmD, BCGP, FASCP, FAzPA, CPAFH Professor of Pharmacy Practice Midwestern University PRACTICE RESOURCE Purchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast. CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current evidence on the use of microdose lithium in Alzheimer's disease. 2. Identify pharmacist considerations for monitoring, patient selection, and safety in the context of lithium micro-dosing for Alzheimer's. Rachel Maynard and Dawn Gerber have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-375-H01-P Initial release date: 12/22/2025 Expiration date: 12/22/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    39 min
  2. New Prescription Option for Fibromyalgia Treatment

    DEC 15

    New Prescription Option for Fibromyalgia Treatment

    Patients with fibromyalgia have waited more than a decade for a new therapeutic option, and a recent regulatory approval signals a shift for these patients. This episode reviews the clinical trial data, mechanism of action, dosing considerations, and pharmacist‑relevant monitoring for the newly approved sublingual formulation of cyclobenzaprine HCl. You will gain practical insights to inform patient education, therapy optimization, and interdisciplinary collaboration in fibromyalgia care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Amanda (Mandy) Mullins, PharmD, BCPS Clinical Pharmacist Practitioner Veterans Affairs PRACTICE RESOURCE Purchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the mechanism of action and key clinical trial outcomes associated with the newly approved prescription medication for fibromyalgia. 2. Identify pharmacist responsibilities for dosing, monitoring adverse effects, and patient counseling when supporting the use of this new fibromyalgia therapy. Rachel Maynard and Amanda (Mandy) Mullins have no relevant financial relationships with ineligible companies to disclose.  0.05 CEU/0.5 Hr UAN: 0107-0000-25-371-H01-P Initial release date: 12/15/2025 Expiration date: 12/15/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    46 min
  3. How OTC Pain Medications May Fuel Antibiotic Resistance

    DEC 8

    How OTC Pain Medications May Fuel Antibiotic Resistance

    Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role in antibiotic resistance. This episode reviews recent findings, explores how these common drugs may influence bacterial response to antibiotics, and highlights pharmacist‑specific considerations. You will walk away with practical insights to support informed medication use and strengthen antibiotic stewardship. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls Hunter O. Rondeau, PharmD, BCIDP, AAHIVP Antimicrobial Stewardship Coordinator, SSM Health Adjunct Clinical Assistant Professor, University of Kansas School of Pharmacy Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.  Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe emerging evidence on how common OTC pain medications may influence antibiotic resistance. 2. Identify pharmacist strategies to optimize analgesic and antibiotic use while supporting antimicrobial stewardship. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-372-H01-P Initial release date: 12/8/2025 Expiration date: 12/8/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    38 min
  4. Navigating the Role of Leucovorin in Autism Care

    DEC 1

    Navigating the Role of Leucovorin in Autism Care

    Recent FDA actions have brought renewed attention to leucovorin as a potential treatment for managing symptoms associated with autism spectrum disorder. This course explores the clinical distinctions between autism and cerebral folate deficiency, reviews key evidence behind leucovorin use, and outlines counseling considerations relevant to pharmacy practice. You will gain clarity on this complex and evolving topic to better support informed, evidence-based care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Geoff Wall, PharmD, FCCP, BCPS Professor of Pharmacy Practice Iowa Methodist Medical Center Rachel Maynard and Geoff Wall have no relevant financial relationships to disclose.     CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current clinical evidence related to the use of leucovorin in autism and cerebral folate deficiency. 2. Identify key counseling considerations for pharmacists discussing leucovorin therapy with patients and caregivers. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-363-H01-P Initial release date: 12/1/2025 Expiration date: 12/1/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    41 min
  5. Antibiotic Essentials - New Approvals and Clinical Refreshers

    NOV 24

    Antibiotic Essentials - New Approvals and Clinical Refreshers

    Pharmacists play a critical role in infectious disease care, and staying up to date on antibiotic therapies is key to ensuring optimal patient outcomes. This episode reviews recently FDA-approved antibiotics, offers a practical refresher on commonly used antibiotic classes, and highlights frequent side effects—along with strategies for managing them in practice. Tune in to strengthen your clinical knowledge and support safe, effective antibiotic use across care settings. HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact GUEST Hunter Rondeau, PharmD, BCIDP, AAHIVP Antimicrobial Stewardship Coordinator SSM Health Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.  Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.    CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify newly FDA-approved antibiotics and their clinical indications. 2. Describe commonly used antibiotic classes, their typical side effects, and strategies to manage or mitigate those effects. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-362-H01-P Initial release date: 11/24/2025 Expiration date: 11/24/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    42 min
  6. Pharmacy's Role with Long-Acting Injectable Medications

    NOV 17

    Pharmacy's Role with Long-Acting Injectable Medications

    Discover the benefits of implementing a long-acting injectable (LAI) service at your pharmacy practice site and the impact this service can have on patient care and outcomes. Listen to this week’s episode and learn how to elevate your pharmacy services!   HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact GUEST Lindsay McCoy, PharmD, BCPP Pharmacy Manager Village Drug Shop at Advantage CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Analyze the benefits and challenges of implementing a long-acting injectable (LAI) service in a pharmacy practice site. 2. Discuss how an LAI service can improve patient care, increase financial sustainability, and optimize patient outcomes. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-354-H01-P Initial release date: 11/17/2025 Expiration date: 11/17/2026 Additional CPE details can be found here. Take your pharmacy practice to the next level with our comprehensive course on the administration of long-acting injectables: Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea 4 hours  |  On Demand Explore a cutting edge clinical service opportunity with this collection of courses specifically designed to equip pharmacists with the knowledge and skills necessary for the effective management and administration of long-acting injectable medications (LAIs). Course content explores diverse drug profiles, advanced administration techniques, and the strategic implementation of LAI-related services to support the needs of your patients and communities. Follow CEimpact on Social Media: LinkedIn Instagram

    34 min
  7. Opioid Use in Palliative and End-of-Life Care

    NOV 10

    Opioid Use in Palliative and End-of-Life Care

    Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood, undertreated, or approached with unnecessary hesitation. This episode explores what pharmacists need to know about assessing opioid appropriateness, questioning therapy when warranted, and supporting comfort-focused care within established clinical and ethical standards. Tune in to build confidence in your role and contribute meaningfully to the care of patients facing serious illness. HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact GUEST Lorin Fisher, PharmD, BCACP Clinical Assistant Professor University of Iowa College of Pharmacy Joshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose. CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:  If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify the role of opioids in managing pain and other symptoms for patients receiving palliative care. 2. Describe key considerations for evaluating opioid prescriptions in the context of serious illness, including appropriate use and safety concerns. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-330-H01-P Initial release date: 11/10/2025 Expiration date: 11/10/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    36 min
  8. RSV Vaccines vs. Monoclonal Antibodies

    NOV 3

    RSV Vaccines vs. Monoclonal Antibodies

    Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season. HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact GUEST Kalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPA Professor University of Florida College of Pharmacy Joshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose.  Pharmacist Members, REDEEM YOUR CPE HERE!   Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode) CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations. 2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-312-H01-P Initial release date: 11/3/2025 Expiration date: 11/3/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    33 min
See All (366)

4.8
out of 5
17 Ratings

About

The CEimpact Podcast features two shows:  GameChangers Clinical Updates  Precept2Practice GameChangers Clinical Update Series: The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/  Precept2PracticeThe Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence.  New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!  Check back each week for our latest episodes. 

Information

  • Creator
    CEimpact
  • Years Active
    2021 - 2025
  • Episodes
    366
  • Rating
    Clean
  • Copyright
    © 2025 CEimpact Podcast
  • Show Website
    CEimpact Podcast

You Might Also Like